May 30, 2016 8:41 PM ET

Capital Markets

Company Overview of Epidarex Capital

Company Overview

Epidarex Capital is a venture capital firm specializing in early stage, startup, and growth capital investments. The firm provides equity capital to young companies including University Spin-outs and under-ventured markets. It seeks to invest in all the life science and health technology companies with a focus on biotechnology, medical devices, pharmaceuticals, personalized medicine and diagnostics, as well as healthcare information technology and services. The firm seeks to invest in the United States and the United Kingdom focusing on Scotland. Epidarex Capital was formerly known as Rock Spring Ventures. Epidarex Capital is based in Bethesda, Maryland with additional offices in Edinburgh, ...

7910 Woodmont Avenue

Suite 1210

Bethesda, MD 20814

United States

Phone:

301-298-5455

Fax:

301-357-8517

Key Executives for Epidarex Capital

Managing Partner
Age: 43
Managing Partner and Co-Founder
Director of Japan
Managing Director, Korea
Compensation as of Fiscal Year 2015.

Epidarex Capital Key Developments

Epidarex Capital Presents at BIO Trinity 2016, Apr-25-2016

Epidarex Capital Presents at BIO Trinity 2016, Apr-25-2016 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Epidarex Capital Presents at BIO-Europe 2015, Nov-02-2015

Epidarex Capital Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Epidarex Capital Presents at Bio-Trinity, May-12-2015 09:25 AM

Epidarex Capital Presents at Bio-Trinity, May-12-2015 09:25 AM. Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom. Speakers: A. Sinclair Dunlop, Managing Partner.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
13D Research (USVI) LLC. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 22, 2016
Topas Therapeutics GmbH
Private Placement
December 24, 2015
Apellis Pharmaceuticals, Inc.
Private Placement
November 4, 2015
Caldan Therapeutics Ltd.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Epidarex Capital, please visit www.epidarex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.